
Lululemon (LULU) has been a severe underperformer in 2025, down ~52% YTD and roughly 50% over the last three and five years (versus S&P 500 gains of ~16% YTD, +69% three years, +88% five years). Despite the weak share price, the company’s fundamentals are strong: five-year revenue has more than doubled and EPS has more than tripled, and FY2024 (ended Feb. 2, 2025) shows North America accounts for ~75% of sales while international net revenue grew 22% in Q2 FY2025. The stock trades at a historically low multiple (~11.5x earnings), implying elevated investor pessimism, but the combination of profitability, international growth runway, and a cheap valuation could present a compelling upside over the next five years.
Market structure: Lululemon's 52% YTD collapse compresses its market cap and removes fire‑power from premium athleisure incumbents; direct winners are international apparel retailers able to fill gaps (fast fashion, Nike NKE for scale) and landlords/discount channels that acquire overstored inventory. Pricing power is bifurcating — North America shows margin and comp‑sales pressure while international (Q2 +22%) creates a runway to re‑rate if management proves scalable execution and FXneutral growth to move international share from ~25% toward 40% over 3–5 years. Risk assessment: Key tail risks are a US consumer pullback causing inventory write‑downs (>5% EPS hit), failed international rollouts (loss of >$200m capex), or a credit shock that widens retail spreads and forces markdowns. Near term (days–weeks) expect volatility and options‑driven flows; medium term (3–12 months) hinge on next two quarters of comps and guide; long term (2–5 years) depends on international doubling and margin recovery to historical mid‑teens operating margins. Trade implications: If comfortable with idiosyncratic recovery, size a staged long: 2–3% portfolio exposure to LULU on confirmed stabilization of NA comps or a close below a fresh low followed by a 10% rebound, target multiple re‑rating to 16–18x over 12–24 months (≈50% upside). Tactical option play: buy 12–18 month LEAP calls (Jan 2026) 25–35% OTM or sell 3–6 month cash‑secured puts 15% OTM to harvest premium and set entry; hedge with 1:1 protection (6–9 month puts) if entering >3% portfolio size. Contrarian angles: The market is pricing permanent structural decline despite revenue doubling and EPS x3 over five years — consensus misses optionality from international scaling and direct‑to‑consumer margin leverage. Reaction appears overdone if management proves modestly competent: a rerating from 11.5x to 16x on stable growth implies ~40–60% upside; unintended consequence is brand dilution or aggressive discounting during expansion which could keep multiples depressed, so require objective operational catalysts (international revenue >20% and sequential NA comp stabilization) before full conviction.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment